Cargando…
A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway
INTRODUCTION: Glutathione reductase (GSR) provides reduced glutathione (GSH) to maintain redox homeostasis. Inhibition of GSR disrupts this balance, resulting in cell damage, which benefits cancer therapy. However, the effect of GSR inhibition on the tumorigenicity of human cervical cancer is not fu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275107/ https://www.ncbi.nlm.nih.gov/pubmed/34262291 http://dx.doi.org/10.2147/OTT.S313507 |
_version_ | 1783721663676809216 |
---|---|
author | Xia, Yuchen Wang, Guihua Jiang, Manli Liu, Xueting Zhao, Yan Song, Yinghui Jiang, Binyuan Zhu, Demao Hu, Ling Zhang, Zhao Cao, Ting Wang, Ji Ming Hu, Jinyue |
author_facet | Xia, Yuchen Wang, Guihua Jiang, Manli Liu, Xueting Zhao, Yan Song, Yinghui Jiang, Binyuan Zhu, Demao Hu, Ling Zhang, Zhao Cao, Ting Wang, Ji Ming Hu, Jinyue |
author_sort | Xia, Yuchen |
collection | PubMed |
description | INTRODUCTION: Glutathione reductase (GSR) provides reduced glutathione (GSH) to maintain redox homeostasis. Inhibition of GSR disrupts this balance, resulting in cell damage, which benefits cancer therapy. However, the effect of GSR inhibition on the tumorigenicity of human cervical cancer is not fully understood. MATERIALS AND METHODS: Tissue microarray analysis was employed to determine GSR expression in cervical cancer tissues by immunohistochemical staining. Cell death was measured with PI/FITC-annexin V staining. mRNA levels were measured via quantitative RT-PCR. Protein expression was measured by Western blotting and flow cytometry. STAT3 deletion was performed with CRISPR/Cas9 technology. GSR knockdown was achieved by RNA interference. Reactive oxygen species (ROS) levels were measured by DCF staining. GSR enzymatic activity was measured with a GSR assay kit. The effect of GSR inhibition on the growth of tumors formed by cervical cancer cells was investigated using a xenograft model. RESULTS: The expression of GSR was increased in human cervical cancer tissues, as shown by immunohistochemical staining. GSR knockdown by RNA interference in human cervical cancer cell lines resulted in cell death, suggesting the ability of GSR to maintain cancer cell survival. The STAT3 inhibitor 6-nitrobenzo[b]thiophene 1,1-dioxide (Stattic) also inhibited the enzymatic activity of GSR and induced the death of cervical cancer cells. More importantly, Stattic decreased the growth of xenograft tumors formed by cervical cancer cells in nude mice. Mechanistically, tumor cell death induced by Stattic-mediated GSR inhibition was ROS-dependent, since the ROS scavengers GSH and N-acetyl cysteine (NAC) reversed the effect of Stattic. In contrast, pharmacological and molecular inhibition of STAT3 did not induce the death of cervical cancer cells, suggesting a STAT3-independent activity of Stattic. CONCLUSION: Stattic inhibits the enzymatic activity of GSR and induces STAT3-independent but ROS-dependent death of cervical cancer cells, suggesting its potential application as a therapeutic agent for human cervical cancers. |
format | Online Article Text |
id | pubmed-8275107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82751072021-07-13 A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway Xia, Yuchen Wang, Guihua Jiang, Manli Liu, Xueting Zhao, Yan Song, Yinghui Jiang, Binyuan Zhu, Demao Hu, Ling Zhang, Zhao Cao, Ting Wang, Ji Ming Hu, Jinyue Onco Targets Ther Original Research INTRODUCTION: Glutathione reductase (GSR) provides reduced glutathione (GSH) to maintain redox homeostasis. Inhibition of GSR disrupts this balance, resulting in cell damage, which benefits cancer therapy. However, the effect of GSR inhibition on the tumorigenicity of human cervical cancer is not fully understood. MATERIALS AND METHODS: Tissue microarray analysis was employed to determine GSR expression in cervical cancer tissues by immunohistochemical staining. Cell death was measured with PI/FITC-annexin V staining. mRNA levels were measured via quantitative RT-PCR. Protein expression was measured by Western blotting and flow cytometry. STAT3 deletion was performed with CRISPR/Cas9 technology. GSR knockdown was achieved by RNA interference. Reactive oxygen species (ROS) levels were measured by DCF staining. GSR enzymatic activity was measured with a GSR assay kit. The effect of GSR inhibition on the growth of tumors formed by cervical cancer cells was investigated using a xenograft model. RESULTS: The expression of GSR was increased in human cervical cancer tissues, as shown by immunohistochemical staining. GSR knockdown by RNA interference in human cervical cancer cell lines resulted in cell death, suggesting the ability of GSR to maintain cancer cell survival. The STAT3 inhibitor 6-nitrobenzo[b]thiophene 1,1-dioxide (Stattic) also inhibited the enzymatic activity of GSR and induced the death of cervical cancer cells. More importantly, Stattic decreased the growth of xenograft tumors formed by cervical cancer cells in nude mice. Mechanistically, tumor cell death induced by Stattic-mediated GSR inhibition was ROS-dependent, since the ROS scavengers GSH and N-acetyl cysteine (NAC) reversed the effect of Stattic. In contrast, pharmacological and molecular inhibition of STAT3 did not induce the death of cervical cancer cells, suggesting a STAT3-independent activity of Stattic. CONCLUSION: Stattic inhibits the enzymatic activity of GSR and induces STAT3-independent but ROS-dependent death of cervical cancer cells, suggesting its potential application as a therapeutic agent for human cervical cancers. Dove 2021-07-05 /pmc/articles/PMC8275107/ /pubmed/34262291 http://dx.doi.org/10.2147/OTT.S313507 Text en © 2021 Xia et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Xia, Yuchen Wang, Guihua Jiang, Manli Liu, Xueting Zhao, Yan Song, Yinghui Jiang, Binyuan Zhu, Demao Hu, Ling Zhang, Zhao Cao, Ting Wang, Ji Ming Hu, Jinyue A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway |
title | A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway |
title_full | A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway |
title_fullStr | A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway |
title_full_unstemmed | A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway |
title_short | A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway |
title_sort | novel biological activity of the stat3 inhibitor stattic in inhibiting glutathione reductase and suppressing the tumorigenicity of human cervical cancer cells via a ros-dependent pathway |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275107/ https://www.ncbi.nlm.nih.gov/pubmed/34262291 http://dx.doi.org/10.2147/OTT.S313507 |
work_keys_str_mv | AT xiayuchen anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT wangguihua anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT jiangmanli anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT liuxueting anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT zhaoyan anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT songyinghui anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT jiangbinyuan anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT zhudemao anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT huling anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT zhangzhao anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT caoting anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT wangjiming anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT hujinyue anovelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT xiayuchen novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT wangguihua novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT jiangmanli novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT liuxueting novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT zhaoyan novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT songyinghui novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT jiangbinyuan novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT zhudemao novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT huling novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT zhangzhao novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT caoting novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT wangjiming novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway AT hujinyue novelbiologicalactivityofthestat3inhibitorstatticininhibitingglutathionereductaseandsuppressingthetumorigenicityofhumancervicalcancercellsviaarosdependentpathway |